CD47 and neoplasm: It has also been found that caerin 1.1/1.9 upregulates CD47 on tumor cells; the combination of caerin 1.1/1.9 intratumor injection, CD47 blockade, and therapeutic vaccination (triple therapy, TT) significantly prolonged survival in B16 tumor-bearing mice [28].